CPNCommunity Pharmacy News – May 2016

PSNC puts counter proposal on the tableAn alternative plan to make better use of community

pharmacy going forward is presented to the Government

Contract monitoring update | New script analysis tool | New-look forms webpage

The counter proposalNot dispensing prescription items if the pharmacy teamdetermines the patient already has sufficient stock

Recommending alternative products to prescribers foritems on a target list of ‘costly’ medicines

Dispensing cheaper generic equivalents in place of certainprescribed branded products

Identifying excess prescribing of medicines and dressingsto care homes

Running annual campaigns encouraging patients to returnunwanted medicines

2 Community Pharmacy News – May 2016

PSNC publishes counter proposalCounter proposal tells Department of Health how community pharmacy

services could be used to make the necessary savings that the NHS needs,

without cutting pharmacy funding.

PSNC has published a summary of the counter proposal it made

to the Department of Health in response to the Government’s

proposals for community pharmacy in 2016/17 and beyond.

The counter proposal sets out how community pharmacy

services, including an emergency supply of medicines service,

could be used to generate the savings the NHS needs to make

through pharmacy, without a cut in funding.

PSNC’s proposal includes plans that would enable pharmacies to

make savings in the prescribing budget and to save on costs for

out of hours GP services. PSNC has also proposed payments that

would reward the provision of high quality pharmacy services, in

response to the Department’s aim to alter community pharmacy

funding distribution mechanisms.

The counter proposal was made to offer a short-term alternative

to the cuts proposed by the Government; PSNC still believes that

the service development proposals it made in February are the

right way forward for community pharmacy, patients and the NHS,

and we are working towards those in the medium to long-term.

Further details of the counter proposal are outlined in PSNC

Briefing 026/16 at: psnc.org.uk/briefings

PSNC has urged David Cameron to reconsider his plans for community pharmacy after the Prime Minister told MPs that he wanted to

see value for money from the sector following massive increases in spending.

The Prime Minister’s comments followed a question from Sue Hayman, Labour MP for Workington, who asked whether the

Government would support independent pharmacies which she said were a vital lifeline for rural communities and helped keep high

streets alive.

PSNC Chief Executive Sue Sharpe responded:

“The Prime Minister could have taken the opportunity to recognise the excellent, front-line work carried out every day in community

pharmacies all over the country. It seems, however, that Mr Cameron was poorly briefed by his officials.

It is not accurate to say that there has been a massive increase in pharmacy spending. The global sum distributed to community

pharmacies has grown significantly slower than inflation and rising volumes of prescriptions. It has also grown slower than overall

funding for the NHS. Community pharmacies provide excellent value for money to the NHS."

psnc’s work funDing anD statistics contract anD it

The counter proposal

Petition reaches one million signatures

The Support your local pharmacy campaign petition made

national papers at the beginning of May as it surpassed the

one millionth signature milestone.

PSNC Chief Executive Sue Sharpe said: “We know just how

much local communities across England value their community

pharmacies and their support for this petition proves that. The

public seems to recognise what the Government so far has

not: that community pharmacy teams are vital front-line NHS

providers who can give face-to-face healthcare advice and

support at a time and place that is convenient for patients.”

Consultation background pack published

The Department of Health (DH) held a stakeholder

engagement event on its consultation on the future of

community pharmacy on 28th April. Slides from the event,

which gave stakeholders the chance to discuss DH’s

proposals in more detail, are now available to view at:

ow.ly/4ncBwO

Also, a background pack, including a summary of

consultation responses so far and ‘source papers’ that were

produced to inform initial discussions with PSNC, can be

downloaded from: ow.ly/4n3uuT

Not dispensing prescription items if thepharmacy team determines the patient

already has sufficient stock

Recommending alternative products toprescribers for items on a target list of‘costly’ medicines

Dispensing cheaper generic equivalents in place of certain prescribed

branded products

Identifying excess prescribing of medicines and dressings to care homes

Running annual campaigns encouragingpatients to return unwanted medicines

PSNC urges Prime Minister to consider alternative pharmacy proposals

�

+

psnc.org.uk 3

services anD commissioning the healthcare lanDscape lpcsDispensing anD supply

CPAF screening survey to be available from JuneThis year’s contract monitoring survey will be available to community

pharmacy contractors from June. The short screening survey removes the

need for all contractors to complete the full CPAF questionnaire.

The 2016/17 Community Pharmacy

Assurance Framework (CPAF) screening

questionnaire will be available via the NHS

Business Services Authority (NHSBSA) from

Monday 6th June for four weeks. It is

anticipated that contractors will receive an

individual email with links to the CPAF

screening questionnaire on or around 6th

June, if not slightly before this date.

The contract monitoring process was

revised by NHS England with the support of

PSNC. The new process requires all NHS

community pharmacy contractors to

complete a short screening questionnaire

consisting of 10 questions; NHS England

will then select only a small number of

pharmacies for a monitoring visit or to

complete the full CPAF questionnaire.

The timing has been chosen to align more

with community pharmacies’ usual

compliance timeframes – avoiding ‘pressure

points’ e.g. particular busy periods such as

the flu season.

NHS England contracted NHSBSA to carry

out the administration of CPAF at a national

level on its behalf and, during last year’s

trial process, this was facilitated by a secure

online mechanism for contractors to

complete their returns.

The PharmOutcomes based CPAF is no

longer used by local NHS England teams

but remains available to contractors for

self-assessment purposes. Additionally, the

full CPAF questionnaire is available on the

NHSBSA website for use as a training tool

or to allow continuous monitoring of

compliance against the community

pharmacy contractual framework..

NHS England has published updated guidance on whistleblowing

policies for healthcare providers. It is hoped that a national,

integrated whistleblowing policy will standardise the way in which

NHS organisations support staff who raise concerns.

Community pharmacy contractors should already have a

whistleblowing policy in place, but they are advised to review the

updated NHS England guidance available at: dld.bz/eznjW

The General Pharmaceutical Council (GPhC) has launched a

consultation on standards for pharmacy professionals.

GPhC is requesting feedback on the proposed standards from

both members of the public and pharmacy professionals by

27th June 2016.

The proposed standards aim to promote professional decision-

making and encourage person-centred care in pharmacy. Respond

to the consultation at: ow.ly/4n3Wif

NHS England publishes whistleblowing policy

Consultation on standards for pharmacy professionals

NHS stationery portal ordersPrimary Care Support England (PCSE) has investigated concerns about delayed supplies of Electronic Prescription Service (EPS)

tokens and late delivery of Drug Tariffs raised by PSNC.

It has been confirmed that some regional variations resulted in a backlog of EPS token orders with stocks being drawn from

PCSE’s distribution centres to make supplies. However, Drug Tariff delivery is carried out by CitySprint on behalf of PCSE and any

pharmacy that does not receive one by the first of the month should email PCSE.enquiries@nhs.net

PCSE is creating a user panel to support its service delivery and needs users like you to share their experiences and give feedback

on future developments. Find out more at: pcse.england.nhs.uk/user-panel

Healthcare news in briefNHS England to tackle conflicts of interest

NHS England has revealed plans to tackle the problem of

conflicts of interests, to provide public reassurance and

confidence in how NHS funding is invested. The

measures announced include revised guidance for

Clinical Commissioning Groups (CCGs), a task and finish

group to develop a full set of rules and proposals, and a

requirement on providers to maintain and publish a

register of gifts, hospitality and conflicts of interest.

NHS England publishes business plan

NHS England has published its business plan for 2016/17,

setting out its main priorities for the coming year. The

priorities are grouped under the following themes:

improving health, transforming care and controlling

costs. PSNC Briefing 025/16 summarises the elements

which are of most relevance to community pharmacy.

For more information on any of these stories, please see

the monthly updates available at: psnc.org.uk/hclbriefings

CheckRx, a companion

service to Check34, will be

available to all contractors

from mid-June. It uses the

prescription item report

(or Px report - see more

information on page

opposite), which the NHS

Business Services

Authority (NHSBSA) offers

to contractors each

month via its website, to

give information on:

• FP34 payment data

(script type, basic

prices, fees paid,

expensive items, etc.);

• Drug Tariff splits of

items dispensed (Part

VIII Category A/M/C

split, Part VIIIB,

appliances, ACBS, etc.);

• Brand/generic analysis

and product usage by volume, value or

number of items;

• Top patients by items dispensed,

identified by their NHS number;

• Which GP practices your scripts come

from, and Electronic Prescription

Service (EPS) nominations; and

• Clinical/therapy area split (by

item/patient).

CheckRx also provides competitor

analysis, showing how pharmacies nearby

are performing. It will show the number

of items they are dispensing, how many

Medicines Use Review (MUR) and New

Medicine Service (NMS) consultations are

being conducted, and their EPS

nominations, as well as which local

surgeries prescriptions originate from.

This information is all sourced from

publically available data on the Health &

Social Care Information Centre (HSCIC)

website.

Contractors will be able to review their

Schedule of Payments – reconstructed

from the Px report using PSNC’s PRISM

pricing tool – and drill down into the

various sections. Other areas on the

dashboard will allow them to see which

are the most frequently dispensed

medicines (selected by value, number or

volume), and which section of the Drug

Tariff their items fall under.

A script source analysis chart shows which

items have been prescribed by which GP

practice, while another area splits items

into clinical or therapeutic category

CheckRx dashboard, showing the six core areas that contractors can click into.

4 Community Pharmacy News – May 2016

psnc’s work funDing anD statistics contract anD it

How you can access CheckRxAs CPN went to press, it was expected the new service will be available to all contractors from mid-June.

The CheckRx subscription fee for a single pharmacy for 12 months will be £144. For contractors who take both services together

(CheckRx and Check34), there will be a £24 discount, equivalent to one month of subscription.

The National Pharmacy Association (NPA) has entered into an arrangement with PSNC Data Systems that means all NPA

members in England will be offered the new service at a preferential rate. It is expected that the NPA will also be managing

subscription sales for CheckRx to any independent pharmacies not currently in NPA membership. Further information will appear

on the PSNC and NPA websites as details become available.

Company Chemists' Association (CCA) members who want to find out more about CheckRx can email

CheckRxadmin@psnc.org.uk or contact PSNC Data Systems on 0203 1220 813 for more information.

CheckRx – a new tool for script item analysisCheckRx is a new service launching soon that gives

community pharmacy contractors easy access to a

wealth of information about the prescription items

they have dispensed.

(using BNF classifications). Finally, a set of

pre-set search filters will allow for

specific searches of all sections of the Px

report.

Clicking on a section of the dashboard,

e.g. Part VIII Category M of the Drug

Tariff, will provide a report of all

dispensed items for that month that fall

into Category M. This can be exported for

further analysis. Clicking on a line (item)

in this report will give all the detail for

the specific item, including

reimbursement paid, endorsements and

fees, and the prescribing practice.

Although CheckRx has its own web

address, it shares the same administration

module as Check34, so users can sign in to

both services using the same user name

and password. Account managers can set

up and structure their company as they

can in Check34. Users will be able to

switch from one service to the other,

provided they subscribe to both.

What is the Px Report?

The Px Report has been available to all

contractors from the NHSBSA since the

beginning of the year. It provides a line by

line reconciliation of what a contractor has

been paid for their prescription bundle for

the relevant month. It details:

• Script type (paper or EPS) and form type

(FP10, FP10MDA, FP10D, etc.);

• Paid, exempt and no charge items;

• Drug description, pack size and basic

price (and SNOMED code);

• Amount paid (at Standard or Zero

Discount Rate);

• Endorsements and fees paid;

• The originating GP practice; and

• A version of the patient’s NHS number.

It is used to compile a substantial part of

the Schedule of Payments (FP34) sent

monthly to every

contractor.

However, the Px report is

not very user friendly! It

is presented as a 72-

column spreadsheet,

with as many rows as

items priced for that

month. There is a 31-

page Transparency

Standard User Guide on

the NHSBSA website that

explains how it all hangs

together, but you need

to be an Excel expert to

apply it to the Px report.

CheckRx does all the

hard work for you,

turning this raw data into

useful business

intelligence for your

pharmacy.Pre-set search filters will enable specific and detailed searches of the Px report.

psnc.org.uk 5

services anD commissioning the healthcare lanDscape lpcsDispensing anD supply

Looking for a simpler way to monitor your prescription

payments?

Want to view key performance indicator trends for your

prescription business?

Hoping to compare your performance with the national

average?

Find out more at: www.check34.com

Understand your NHS business better with Check34

Not yet got an account?

Email check34admin@psnc.org.uk for more information.

How you might put CheckRx touse in your pharmacy:• Identify missing fees/incorrect endorsements (e.g.

Schedule 2/ 3 Controlled Drug scripts);

• Determine which items you are dispensing at a loss

(e.g. branded generics);

• Expensive items reconciliation;

• Ensure supplementary fees are correctly paid;

• Understanding product usage (Drug Tariff category

splits/generic/branded);

• Inform stock management and purchasing decisions

(generic tendering, Non-Tariff programmes);

• Competitor analysis (prescription drift, EPS

nomination); and

• Understanding therapeutic categories and patient

groups to deliver clinically-focussed community

pharmacy services locally.

An evaluation of the Community Pharmacist Domiciliary Visit service

in Cornwall found that nearly half of visits led to identification of

wasted medicines and 86.3% resulted in a cost saving to the NHS.

It also includes a recommendation that the service is commissioned

in all pharmacies across Cornwall so more housebound patients can

benefit from the valuable service.

The service involves a community pharmacist visiting an older

housebound patient in their own home for an informal conversation,

allowing the patient to tell their story and voice their concerns in a

familiar environment.

This service is different to domiciliary Medicines Use Reviews in that

there is no structured questioning; rather, open-ended questions are

posed with a Visit Form being used as a conversation guide only. The

pharmacist assesses the patient’s adherence, understanding of their

condition and treatment, and offers lifestyle support as well as the

removal of unwanted medicines for safe disposal.

The resulting action plan is shared (with the patient’s consent) with

their GP and any other appropriate member of the patient’s

healthcare team.

Funding for the service has been provided by the Prime Minister’s GP

Access Fund (formerly known as the Challenge Fund), the South West

Clinical Network Group, and Kernow Clinical Commissioning Group.

6 Community Pharmacy News – May 2016

lpcs psnc’s work funDing anD statistics

Domiciliary Visit service offers significant benefitsMore than 85% of the interventions made in a Domiciliary Visit service

saved the NHS money as well as providing a valuable service to housebound

patients in Cornwall.

A new national company, Community Provider Support Services Ltd (CPSS), has

been set up with the support of the national pharmacy bodies.

The purpose of the company – initiated by AIMp, CCA, NPA and PSNC – is to advise

and support LPCs and their community pharmacy contractors in negotiations with

local authorities and other commissioners.

The first major task for the board of directors, made up of representatives from

PSNC and the NPA, is to scope, agree and price a compelling offer and prospectus

of pharmacy services to support tenders for local commissioning.

New company to support service development

Read the article in full at: ow.ly/4mRrXj

Evaluationhighlights

Healthcare news in briefPublic Health England publishes strategic plan

Public Health England (PHE) has published its strategic plan,

setting out how it plans to achieve its aims over the next four

years. The report also confirms PHE’s role in building on

evidence, prioritising prevention and supporting local

government and the NHS.

NHS England backs innovative care initiative

NHS England has announced it will invest £1.75m in a new,

innovative ‘Shared Lives’ model. The family-based initiative

aims to support more people being cared for in a home, rather

than a hospital, by matching people with special needs to a

Shared Lives carer.

30.5%of patients are likely to haveavoided a hospital admission

Nearly half of patientshad wasted or excess medicines

One in 20were within the classes of vulnerable

to severely frail

86.3%of visits resulted

in a cost saving

New PSNC RegionalRepresentative elected

Sunil Kochhar, Vice Chair of Kent LPC, has

been elected as PSNC’s South East Coast

regional representative.

PSNC would like to welcome Sunil to the

team and very much look forward to

working closely with him to promote

community pharmacy in England.

psnc.org.uk 7

Dispensing anD supply services anD commissioning the healthcare lanDscapecontract anD it

Making the Accessible InformationStandard work for you

The Centre for Pharmacy Postgraduate Education (CPPE) has developed a programme to support

community pharmacy teams in implementing the Accessible Information Standard.

We are launching an e-learning programme aimed at helping you and your pharmacy team to

implement the Accessible Information Standard, which is mandatory by 31st July 2016. Preparations

should already be underway in community pharmacies so this e-learning’s arrival is timely and

relevant.

Accessible Information Standard – making it work helps pharmacy teams through the five-step

approach given in the Standard’s requirements. Teams must elicit, record, flag, share and meet the

communication needs of all their customers and patients.

It also requires pharmacists and their teams to meet the communication needs of everyone with

whom they come into contact, at first registration and at every contact thereafter. The Standard is

aimed particularly at people with some sensory loss such as hearing and sight.

The requirement further stretches pharmacy teams

and their resources, so our e-learning programme

suggests meeting to discuss the development of a

standard operating procedure and to decide who will

be responsible for taking the lead on the Standard’s

implementation.

The programme follows each of the five steps, considering the requirements, what

this means for pharmacy teams, and suggesting how pharmacy teams may meet the

requirements. It also provides substantial signposting to useful resources.

This new CPPE e-learning programme was developed following Hertfordshire LPC

successfully winning an implementation bid from NHS England.

You can access the e-learning by logging into the CPPE website at:

www.cppe.ac.uk/ais (please note you may need to register for access).

Geraldine FlavellRegional Manager,

West Midlands

“

Briefing published on Accessible Information StandardPSNC and Pharmacy Voice have produced a

briefing on the Accessible Information

Standard.

NHS England's new Standard will become a

legal requirement for providers of NHS and

social care services in England, including

community pharmacies, on 31st July 2016.

The purpose of the joint briefing is to

update community pharmacy contractors

on the requirements of this Standard, as

well as explaining what steps they need to

take next.

Download the PSNC and Pharmacy Voice

briefing from: ow.ly/4n6Y11

Links to further resources

NHS England’s Accessible Information

Standard webpage:

www.england.nhs.uk/accessibleinfo

An interactive programme on

implementing the Standard:

tinyurl.com/AISprogramme

New consultationskills programmeCPPE has launched an interactive,

video-based course called

Consultation skills: what good practice

looks like.

The programme allows the learner to

watch experts demonstrate what a

patient-centred approach is by

showcasing key skills and behaviours.

Find out more about this course at:

dld.bz/exPVy

Intelligence packs offer prevention opportunities

The National Cardiovascular Intelligence Network has launched

the second edition of its Cardiovascular Disease (CVD) Primary

Care Intelligence Packs. The packs are a resource for Clinical

Commissioning Groups (CCGs) and practices to help improve

health outcomes in CVD by identifying gaps in primary care.

Three million benefit from new NHS programme

Three million patients have begun accessing apps, devices and

online networks from the NHS Innovation Accelerator

programme. The programme gives innovators support to roll

out their technology or service.

For more information on any of these stories, please see the monthly updates available at: psnc.org.uk/hclbriefings

“

8 Community Pharmacy News – May 2016

psnc’s work funDing anD statistics contract anD it

In this section of Community Pharmacy News we have highlighted some keynotices for you and your team to be aware of in the coming weeks and months.

Pharmacy notice board

Hints & Tips for dispensing contractorsThe latest issue (number 23) of the Pricing Authority’s Hints & Tips for dispensingcontractors newsletter contains some really useful information on:

Accessing links for Drug Tariff Part IX as csv and Excel files;Claiming out of pocket expenses;Electronic Prescription Service (EPS) exemption/charge paid status;Excessive quantities in EPS Release 2; and The end of month submission process, including EPS Release 2 claims.

You can read issue 23 on the Pricing Authority’s website: www.nhsbsa.nhs.uk/3191.aspx

Research bursary openfor applicationsPharmacists have until 30th Juneto apply for the National Pharmacy Association'sHealth Education Foundation bursary forresearch in community pharmacy practice.Find out more and download your applicationpack here: ow.ly/4mQApe

A practical guide for carersA guide encouraging carers to check with their local pharmacy about services that might help makelife easier has been published by NHS England, in partnership with Carers UK, Carers Trust, Age UK,Public Health England and older carers themselves.

The guide aims to provide carers with advice, hints and tips on a range of issues they may face suchas how to cope with caring for someone, getting help and using technology. Case studies are featuredin the guide as well as a list of useful contacts and an action plan for carers.

Pharmacy teams can order free copies of the guide to provide to carers by phoning Prolog on 0300123 1002, quoting reference HC1, or online at: www.orderline.dh.gov.uk

PSNC Leadership Academy updateThe PSNC Leadership Academy trainees had their second training day

in London on 19th April.

‘Managing and leading through change’ was the theme for the day –

particularly apt for those working in the community pharmacy

sector at the moment.

PSNC will be talking to some of the candidates in more depth next

month.

Change to PricingAuthority’s email address

The Pricing Authority has changed its main

customer enquiries email address to:

nhsbsa.prescriptionservices@nhsbsa.nhs.uk

Their old email address, ending in

@nhs.net is now no longer in use

and is not being monitored.

Community pharmacy contractors will see a ‘year to

date total’ of Medicines Use Review (MUR) claims

on their monthly FP34 Schedule of Payments from

April 2016.

The ‘year to date total’ has been introduced to

assist contractors with monitoring the number of

MURs claimed during the financial year.

NHS England has contracted the NHS Business Services Authority (NHSBSA) to take

on the role of monitoring MUR activity and recovering payments from contractors

for any claims made in excess of the 400 limit for each financial year.

Contractors who claim for more than 400 MURs will receive a letter from NHSBSA

stating the cumulative total of MURs claimed, the value of the payment to be

recovered and notice of the recovery date.

psnc.org.uk 9

services anD commissioning the healthcare lanDscape lpcsDispensing anD supply

Have you seen our new-look prescription forms page?

Cumulative MUR total added to Schedule of Payments

Year to date totals to be included on the FP34 Schedule of Payments for the

first time to support monitoring of MURs claimed over the financial year.

Healthcare newsin briefProgress in health devolution

The Local Government Association has

published a briefing document outlining the

broad lessons that can be learnt from

Greater Manchester’s experience of health

devolution. It also discusses the positives,

ongoing challenges and key themes from

the devolution roundtable discussions.

Older People’s Health and Wellbeing

Public Health England has published the

Older People’s Health and Wellbeing

Profile, a tool which can be used to examine

the health and care of older people across

local authorities in England. The tool

contains 95 interactive indicators and allows

comparison and monitoring of trends in

different regions.

Sustainability and Transformation

Regional Voices has published a short

briefing explaining Sustainability and

Transformation Plans and their role in

delivering the NHS Five-Year Forward View.

It also provides guidance on how to get

involved in local areas.

For more information on any of these stories,

please see the monthly updates available at:

psnc.org.uk/hclbriefings

The PSNC Dispensing and Supply Team is currently in the process of updating the

pages in the Dispensing and Supply section of the PSNC website.

The updated ‘Is this prescription form valid?’ page provides information on which

form types are valid, who they are used by and much more. See below for a look at

our new easy to use chart.

Head over there now using our shortlink: psnc.org.uk/prescriptionforms

Changes to Part VIIIBA number of products were added to Part

VIIIB of the Drug Tariff in May 2016, namely:

• Pizotifen 250micrograms/5ml oral

solution;

• Pizotifen 250micrograms/5ml oral

suspension;

• Pyridostigmine bromide 50mg/5ml oral

suspension; and

• Tamsulosin 400micrograms/5ml oral

suspension.

A full list of products and new

reimbursement prices can be found in Part

VIIIB of the May 2016 Drug Tariff.

The listings for four Part VIIIA entries of Midazolam oromucosal

solution pre-filled oral syringes changed from 1st May 2016 to

recognise the sugar-free (SF) status of this product. The listings

were deleted from the Drug Tariff and replaced with SF versions.

The Department of Health has granted a concession period for

the month of May to avoid confusion amongst prescribers and

pharmacy teams, and to allow time for system suppliers to

update their systems. Prescriptions written with the old

description will continue to be reimbursed against Buccolam or

based on endorsement if an ‘unlicensed special’ is supplied during

this time. The concession has been put in place to avoid

prescriptions being returned to pharmacies for clarification which

could lead to a delay in payment.

From 1st June 2016, contractors need to ensure that any

prescription written generically for Midazolam oromucosal

solution pre-filled oral syringes reads as per the new name.

Previous name (deleted) New name (added)

Midazolam 10mg/2ml oromucosal solution pre-filled oral syringes Midazolam 10mg/2ml oromucosal solution pre-filled oralsyringes SF

Midazolam 2.5mg/0.5ml oromucosal solution pre-filled oralsyringes

Midazolam 2.5mg/0.5ml oromucosal solution pre-filled oralsyringes SF

Midazolam 5mg/1ml oromucosal solution pre-filled oral syringes Midazolam 5mg/1ml oromucosal solution pre-filled oralsyringes SF

Midazolam 7.5mg/1.5ml oromucosal solution pre-filled oralsyringes

Midazolam 7.5mg/1.5ml oromucosal solution pre-filled oralsyringes SF

10 Community Pharmacy News – May 2016

Dispensing anD supply services anD commissioning the healthcare lanDscape lpcs

Community pharmacy teams must check whether the items prescribed on NHS prescriptions are allowed on the NHS before dispensing them. Thecontractor will not be paid for them if they are not allowed.

Pharmacy teams may wish to check PSNC’s ‘Dispensing on an FP10 database’ (available at: psnc.org.uk/FP10database) for more information onwhether an item can be dispensed on an FP10. Below is a list of some products that we have recently received queries about.

Product Is the item Is it Does it Can it be Additional listed in the in the have a ‘CE’ dispensed information Drug Tariff? blacklist? mark? on an FP10?

Please note: If the prescription is one of the following, pharmacy staff will need to check the relevant sections of the Drug Tariff/PSNC website:

• FP10CN or FP10PN (community nurse prescriber) – Part XVIIB

• FP10D (dental prescriber) – Part XVIIA

• FP10MDA (instalment dispensing) – psnc.org.uk/mda

Can it be dispensed on an FP10?

Tubegauz stockinette (all

sizes)

UltraDEX Oral Rinse

Dexcom G5 Mobile

Continuous Glucose

Monitoring System

Sterile polythene jug 1ltr

AirLife sterile water for

inhalation

No

No

No

No

No

Yes

No

Yes

Yes

Yes

n/a

No

n/a

n/a

n/a

No

Yes

No

No

No

This item is a medical device (CE marked) and is not listed

in Part IX of the Drug Tariff.

This item is not a medical device (CE marked) and does

not appear in Part XVIIIA (the ‘blacklist’) of the Drug Tariff.

This item is a medical device (CE marked) and is not listed

in Part IX of the Drug Tariff.

This item is a medical device (CE marked) and is not listed

in Part IX of the Drug Tariff.

This item is a medical device (CE marked) and is not listed

in Part IX of the Drug Tariff.

Drug Tariff listing change for MidazolamCommunity pharmacy contractors should be aware of

changes made to the May Drug Tariff and the Dictionary

of Medicines and Devices (dm+d) listings for Midazolam

oromucosal solution pre-filled oral syringes.

If you would like more information on any of the topics covered, the PSNC Dispensing and Supply Team will be happy to help (0844 381 4180 or 0203 1220 810 or e-mail info@psnc.org.uk).

psnc.org.uk 11

psnc’s work funDing anD statistics contract anD it

All details correct at time of printing.

No part of this publication may be reproduced without the written permission of PSNC.

Produced for PSNC by Communications International Group. ©. PSNC.

Colour repro and printing by Truprint Media, Margate.

The publishers accept no responsibility for any statement made in signed contributions or

in those reproduced from any other source.

Communications International Group

Linen Hall, 162-168 Regent Street, London W1B 5TB

Tel: 020 7434 1530 Fax: 020 7437 0915

Distributedfor PSNC by:

lpcs

Ask PSNCThe PSNC Dispensing and Supply Team can provide pharmacy teams with

support and advice on a range of topics related to the Drug Tariff and

reimbursement. Questions asked in recent months have included:

Q. If a prescription was dispensed before1st April but the patient didn't collect ituntil after 1st April, should the patientpay the old or new prescription charge?

Q. A patient has ticked the maternity exemptionbox on the back of their prescription, but they haveonly applied for a maternity exemption certificatetoday. Can the patient claim the exemption orshould they pay the prescription charge?

A. There is no national guidance on this issue so pharmacy staff willbe required to exercise their professional judgement. Whatever thedecision, pharmacy staff are advised to record the charge made andthe reasons for doing so on the patient’s medication record.

A. The patient should pay for their prescription and be issuedwith an FP57 (Receipt and Refund Form) so that they may claimback the charges once they receive their maternity exemptioncertificate. Details of prescription charge refunds and the claimprocedure can be found on our website: psnc.org.uk/refunds

Q. Do I need to display a noticeabout the NHS prescription charge? A. Yes, it is part of your Terms of Service to have a notice in the prescription

reception area about the NHS prescription charge. For further information,please see the clinical governance approved particulars for premises (availablefrom: psnc.org.uk/cg).

Health Committee says primarycare is under strain

The House of Commons Health

Committee has published a report,

Primary Care, which sets out the

challenges faced by primary care and

analyses long-term solutions to drive

improvements in patient care. The

report also examines patients’ and the

workforce’s experience of primary care,

the new models of care, building the

new primary care team and funding.

Charity proposes assessment ofNHS funding

The Patients Association has announced

proposals to establish an independent

commission to examine funding levels

against the current and future needs of

the NHS and social care. The commission

will consider how much to spend as a

society, as well as possible sources of

additional funding, using the principle of

free treatment at the point of care as a

starting point.

Prescription figures published

The Health & Social Care Information

Centre (HSCIC) has published its

Prescription Cost Analysis (PCA) report,

providing data on all prescriptions

dispensed in the community across

England. The 2015 PCA report states

1.08bn prescription items were

dispensed (up by 1.8%) at a cost of

£9.27bn (up by 4.7%).

Healthcare news in brief

For more information on any of these stories, please see the monthly updates available at: psnc.org.uk/hclbriefings

Dispensing anD supply services anD commissioning the healthcare lanDscape

PSNC websiteFor up to date information and news on community pharmacy issues, visit the PSNC website at psnc.org.uk

PSNC Community Pharmacy News is published by:The Pharmaceutical Services Negotiating Committee, Times House, 5 Bravingtons Walk, London N1 9AWCommunity Pharmacy News is edited by:Melinda Mabbutt who can be contacted at the above address or by email at: mmabbutt@psnc.org.uk © PSNCPSNC Office: 0844 381 4180 or 0203 122 0810

Drug Tariff WatchThe Preface lists additions, deletions and alterations to the Drug Tariff. Below is a quick summary of

the changes due to take place from 1st June 2016. You may also wish to see our Dispensing Factsheet:

The Drug Tariff Preface at: psnc.org.uk/dtresources

SC Special Container

* This pack only (others already available)

Part VIIIA additions

Category A:

• Atropine 1mg/1ml solution for injection

ampoules (10)

• Atropine 400micrograms/1ml solution

for injection ampoules (10)

• Timolol 10mg / Bendroflumethiazide

2.5mg tablets (30)

Category C:

• Adrenaline (base) 300micrograms/0.3ml

(1 in 1,000) solution for injection pre-

filled disposable devices SC (1) – EpiPen

• Lidocaine 4% cream SC 5g – LMX 4

• Liquid paraffin light 63.4% bath

additive SC (150ml) – Oilatum Bath

Formula

• Liquid paraffin light 63.4% bath

additive SC (250ml) – Oilatum Emollient

• Liquid paraffin light 63.4% bath

additive SC (300ml) – Oilatum Bath

Formula

• Liquid paraffin light 63.4% bath

additive SC (500ml) – Oilatum Emollient

• Liquid paraffin light 63.4% bath

additive SC (600ml) – Oilatum Junior

• *Mesalazine 800mg gastro-resistant

tablets (84) – Asacol MR

• Riluzole 25mg/5ml oral suspension sugar

free (300ml) – Teglutik

• White soft paraffin 15% / Liquid paraffin

light 6% cream SC (50g) – Oilatum

• White soft paraffin 15% / Liquid

paraffin light 6% cream SC (150g) –

Oilatum

• White soft paraffin 15% / Liquid paraffin

light 6% cream SC (350ml) – Oilatum

Junior

• White soft paraffin 15% / Liquid paraffin

light 6% cream SC (500ml) – Oilatum

• White soft paraffin 15% / Liquid paraffin

light 6% cream SC (1050ml) – Oilatum

Part VIIIA amendments

• Betaxolol 0.5% eye drops SC (5ml) is

changing to Category C – Betoptic

• Clomifene 50mg tablets (30) is changing

to Category C – Clomid

• Co-trimoxazole 160mg/800mg tablets

(100) is changing to Category C – Aspen

Pharma Trading Ltd

• Frovatriptan 2.5mg tablets (6) is

changing to Category A

• Gliclazide 30mg modified-release tablets

(28) is changing to Category C –

Diamicron MR

• Indometacin 75mg modified-release

capsules (100) is changing to Category

C – Berlind 75 Retard

• Mesalazine 800mg gastro-resistant

tablets (180) is changing to Category C –

Octasa MR

• Nitrazepam 2.5mg/5ml oral suspension

(70ml) is changing to Category A

• Pholcodine 10mg/5ml linctus strong

sugar free (2000ml) is changing to

Category C – Galenphol Strong

• Pindolol 5mg tablets (100) is changing to

Category A

• Propranolol 80mg modified-release

capsules (28) is changing to Category C –

Half Beta-Prograne

• Rasagiline 1mg tablets 28 is changing to

Category A

• Tioconazole 283mg/ml medicated nail

lacquer SC (12ml) is changing to

Category A

Part VIIIA deletions

If a medicinal product has been removed

from Part VIIIA, and has no other pack

sizes listed, it can continue to be

dispensed as long as the product does not

appear in Part XVIIIA (the ‘Blacklist’).

However, it will need to be endorsed fully

(i.e. brand or supplier name and the pack

size from which the item was dispensed).

• Co-danthramer 37.5mg/500mg

capsules (60) Category C – A A H

Pharmaceuticals Ltd

Part IX deletions

It is important to take careful note of removals from Part IX because, if you dispense a deleted product, prescriptions will be returned

as disallowed and therefore payment will not be made for dispensing the item.

Product Type, size and product code

LoFric Hydro-Kit catheter (Wellspect HealthCare) Tiemann, 10-18 Gauge (Ch), codes 9871000-9871800

Versiva XC dressing (with Adhesive Border) Square: 10cm x 10cm, 14cm x 14cm, 19cm x 19cm, 22cm x 22cmHeel: 18.5cm x 20.5cmSacral: 21cm x 25cm

Versiva XC dressing (without Adhesive Border) Square: 7.5cm x 7.5cm, 11cm x 11cm, 15cm x 15cm, 20cm x 20cm

Sorbion silver flex dressing Square: 5cm x 5cm, 10cm x 10cm, 20cm x 20cm Rectangular: 10cm x 20cm

MediSafe Solo lancets (Cambridge Sensors Ltd) 0.50mm/29 gauge